Thomas Bolland
Director
Surgical
Spine Guard Company
France
Biography
Thomas Balland is an investment director and specializes in software, wireless and medical devices investments. He assesses investment opportunities, conducts due diligence, leads negotiations and transaction closings, and actively monitors portfolio companies. Thomas currently serves on the boards of Aupeo, Club Cooee, CMC Biologics, Ingen BioSciences, Navx, SpineGuard, SpineVision, SymbioFCell and Traqueur (Alternext: ALTRA). He is responsible for investments in Paion (Frankfurt Stock Exchange: PA8). Thomas sat on the Board of Innoven portfolio company gate5 AG, which was sold to Nokia in 2006. He was also involved with Digiplug, sold to Faith (Tokyo Stock Exchange: 4295) and ProStrakan (listed on the LSE, and then acquired by Kirin in 2011). Thomas has over 10 years of venture capital investment experience. Prior to joining Innoven in 2002, he held various positions with firms such as Mars Inc., Up&Up and Vivendi. Thomas received dual degrees in engineering and finance from INSA Lyon and ESCP-EAP respectively.
Research Interest
capital investment
